Botulinum toxin type A for Levodopa-induced cervical dyskinesias in Parkinson's disease: Unfavorable risk-benefit ratio§

Authors

  • Alberto J. Espay MD, MSc,

    Corresponding author
    1. The Neuroscience Institute, Department of Neurology, Movement Disorders Center, University of Cincinnati, Cincinnati, Ohio, USA
    • The Neuroscience Institute, Department of Neurology, Movement Disorders Center, University of Cincinnati, Cincinnati, Ohio, USA
    Search for more papers by this author
  • Jennifer E. Vaughan BPhil,

    1. The Neuroscience Institute, Department of Neurology, Movement Disorders Center, University of Cincinnati, Cincinnati, Ohio, USA
    Search for more papers by this author
  • Rakesh Shukla PhD,

    1. Center for Biostatistical Services, Department of Environmental Health, University of Cincinnati, Cincinnati, Ohio, USA
    Search for more papers by this author
  • Maureen Gartner RN, MEd,

    1. The Neuroscience Institute, Department of Neurology, Movement Disorders Center, University of Cincinnati, Cincinnati, Ohio, USA
    Search for more papers by this author
  • Alok Sahay MD,

    1. The Neuroscience Institute, Department of Neurology, Movement Disorders Center, University of Cincinnati, Cincinnati, Ohio, USA
    Search for more papers by this author
  • Fredy J. Revilla MD,

    1. The Neuroscience Institute, Department of Neurology, Movement Disorders Center, University of Cincinnati, Cincinnati, Ohio, USA
    Search for more papers by this author
  • Andrew P. Duker MD

    1. The Neuroscience Institute, Department of Neurology, Movement Disorders Center, University of Cincinnati, Cincinnati, Ohio, USA
    Search for more papers by this author

  • Allergan, Inc. had no role in study design, data collection, data analysis, data interpretation, or writing of the report.

  • Relevant conflict of interest/financial disclosures: Nothing to report.

  • §

    Full financial disclosures and author roles may be found in the online version of this article.

No abstract is available for this article.

Ancillary